Dr Jane Carr-Wilkinson Dr Nilendran Prathalingam Dr Deepali Pal Dr Mohammad Moad Dr Peter James et al. | Differentiation of human embryonic stem cells to sympathetic neurons: A model for understanding neuroblastoma pathogenesis. | 2018 |
|
Dr Deepali Pal Anastasia Rigas Dr Stuart Williamson Dr Mohammad Moad Dr Jane Carr-Wilkinson et al. | Induced pluripotent stem cell (iPSC) re-programming in the human prostate | 2012 |
|
Dr Jane Carr-Wilkinson Bojidar Goranov Dr Chris Redfern Dr Laura Gamble Professor John Lunec et al. | Outcome of the p53-mediated DNA damage response in neuroblastoma is determined by morphological subtype and MYCN expression | 2011 |
|
Dr Jane Carr-Wilkinson Kieran O'Toole Angela Baker Julian Board Mike Cole et al. | High frequency of p53/MDM2/p14ARF pathway abnormalities in relapsed neuroblastoma | 2010 |
|
Dr Jane Carr-Wilkinson Dr Nicholas Bown Marian Case Dr Andrew Hall Professor John Lunec et al. | High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays | 2007 |
|
Dr Jane Carr-Wilkinson Dr Emma Bell Professor Andrew Pearson Professor John Lunec Professor Deborah Tweddle et al. | Increased frequency of aberrations in the p53/MDM2/p14ARF pathway in neuroblastoma cell lines established at relapse | 2006 |
|
Dr Emma Bell Dr Jane Carr-Wilkinson Dr Xiaohong Lu Professor Penny Lovat Professor John Lunec et al. | The role of MYCN in the failure of MYCN amplified neuroblastoma cell lines to G1 arrest after DNA damage | 2006 |
|
Dr Jane Carr-Wilkinson Julian Board Dr Katrina Wood Professor Andrew Pearson Professor John Lunec et al. | Selection for p53 mutant cells by chemotherapy in high-risk neuroblastoma | 2003 |
|